Press "Enter" to skip to content

New patent for Deciphera Pharms drug QINLOCK

1
Copyright © DrugPatentWatch. Originally published at New patent for Deciphera Pharms drug QINLOCK

Annual Drug Patent Expirations for QINLOCK
Annual Drug Patent Expirations for QINLOCK

Qinlock is a drug marketed by Deciphera Pharms and is included in one NDA. There are three patents protecting this drug.

This drug has twenty-seven patent family members in ten countries.

The generic ingredient in QINLOCK is ripretinib. Additional details are available on the ripretinib profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Deciphera Pharms drug QINLOCK

Comments are closed.

Online Certificate Course

Decision-Making for Generic Drug Entry & Branded Drug Lifecycle Management

  • When will key drug patents expire?
  • How can I find, evaluate, and plan for generic market entry opportunities?
  • How can I find proprietary out-of-court settlements and deal terms?
DrugPatentWatch - Make Better Decisions